Technical Comparison
Amylyx Pharmaceuticals, Inc. - Common Stock vs NVIDIA Corporation - Common Stock
Real-time financial comparison matrix between AMLX and NVDA.
Primary Asset
AML
Amylyx Pharmaceuticals, Inc. - Common Stock
Market Rank #1000275Live Price$29.40
Market Capitalization$3.7B
24h Change+0.68%
Circulating Supply126M AMLX
Comparison Asset
NVD
NVIDIA Corporation - Common Stock
Market Rank #101Live Price$200.13
Market Capitalization$4.8T
24h Change-3.17%
Circulating Supply24B NVDA
Market Metric Matrix
| Comparison Metric | AMLX Value | NVDA Value | Dominant Asset |
|---|---|---|---|
| Market Cap Rank | #1000275 | #101 | NVIDIA Corporation - Common Stock |
| Unit Price Valuation | $29.40 | $200.13 | NVIDIA Corporation - Common Stock |
| Total Liquid Cap | $3.7B | $4.8T | NVIDIA Corporation - Common Stock |
Frequently Asked Questions
Is Amylyx Pharmaceuticals, Inc. - Common Stock bigger than NVIDIA Corporation - Common Stock?
Amylyx Pharmaceuticals, Inc. - Common Stock has a market cap of $3.7B, while NVIDIA Corporation - Common Stock sits at $4.8T. Therefore, NVIDIA Corporation - Common Stock is currently the larger financial asset by market capitalization.
What is the price ratio between Amylyx Pharmaceuticals, Inc. - Common Stock and NVIDIA Corporation - Common Stock?
Currently, 1 AMLX is worth 0.15 NVDA.